Email Updates

Search form

You are here

Multipurpose Prevention Technologies

HIV prevention and women’s reproductive health go hand in hand.

HIV prevention doesn’t happen in isolation. Even when people are at high risk for HIV, avoiding infection is but one factor in a complex set of decisions about their health and well-being. For women worldwide, those decisions include childbearing and reproductive and sexual health.

Multi-purpose prevention technologies are now in development to simultaneously prevent unintended pregnancy and protect against HIV and other sexually transmitted infections. By addressing multiple health concerns in convenient, easy-to-use formulations, these technologies might also help ensure high levels of product adherence. Multiple versions are entering early clinical trials now. Many important questions about efficacy, acceptability and adherence need to be addressed as this research proceeds.

What We're Reading

The push to increase women’s ability to protect themselves from both unintended pregnancy, HIV, and other sexually transmitted infections, has taken another step with the start of a new trial of a long-acting vaginal ring using the drug dapivirine, and the hormone levonorgestrel. AHC Media, a publication for health professionals, reports on this early phase study of 24 women, based in the U.S.

August 1, 2017
AHC Media

The Economist has this story on the International Partnership for Microbicides’ (IPM) trial testing a vaginal ring that couples HIV prevention with pregnancy prevention.

May 4, 2017
The Economist
Subscribe to RSS - Multipurpose Prevention Technologies